BioXcel Therapeutics Files 8-K for Other Events
Ticker: BTAI · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1720893
Sentiment: neutral
Topics: 8-K, corporate-event
TL;DR
BioXcel Therapeutics filed an 8-K for 'Other Events' on 3/20/25. Details TBD.
AI Summary
BioXcel Therapeutics, Inc. filed an 8-K on March 21, 2025, reporting an event that occurred on March 20, 2025. The filing pertains to 'Other Events' and does not specify any material agreements, acquisitions, or financial transactions within the provided text. The company is incorporated in Delaware and its principal executive offices are located at 555 Long Wharf Drive, New Haven, CT.
Why It Matters
This 8-K filing indicates a corporate event has occurred for BioXcel Therapeutics, requiring disclosure to the SEC. Investors should review the full filing for details on the nature of this event.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not contain specific financial or operational information that would immediately indicate high risk.
Key Players & Entities
- BioXcel Therapeutics, Inc. (company) — Registrant
- March 20, 2025 (date) — Date of earliest event reported
- March 21, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of incorporation
- 555 Long Wharf Drive, New Haven, CT 06511 (address) — Principal executive offices
FAQ
What specific event is reported under 'Other Events' in this 8-K filing?
The provided text for the 8-K filing does not specify the details of the 'Other Events' beyond the general category.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on March 21, 2025.
What is the date of the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 20, 2025.
In which state is BioXcel Therapeutics, Inc. incorporated?
BioXcel Therapeutics, Inc. is incorporated in Delaware.
What is the address of BioXcel Therapeutics, Inc.'s principal executive offices?
The principal executive offices of BioXcel Therapeutics, Inc. are located at 555 Long Wharf Drive, New Haven, CT 06511.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding BioXcel Therapeutics, Inc. (BTAI).